CTI BioPharma Corp.
METHODS OF TREATING FLT3-MUTATED HEMATOLOGIC CANCERS
Last updated:
Abstract:
Methods to inhibit FLT3 activity in a subject or a cell with an FLT3 mutation are provided. Methods of treating a hematologic cancer, such as acute myeloid leukemia, in a subject identified as having an FLT3 mutation, are also provided.
Status:
Application
Type:
Utility
Filling date:
1 Oct 2019
Issue date:
13 Jan 2022